Categories AlphaGraphs, Earnings, Health Care

SmileDirectClub (SDC) Q1 Report: Net loss narrows but misses estimates

Digital healthcare firm SmileDirectClub Inc. (NASDAQ: SDC) reported a narrower net loss for the first quarter of 2021 amid modest revenue growth. While the bottom-line missed Wall Sreet’s prediction, revenues beat.

SmileDirectClub Q1 2021 earnings infographic

The Nashville, Tennessee-based teledentistry company reported a net loss of $28.9 million or $0.25 per share for the March quarter, which marked an improvement from the year-ago period when it incurred a loss of $29.3 million or $0.28 per share. Analysts were looking for a narrower loss for the latest quarter.

At $199.5 million, first-quarter revenues were up 1% from the comparable period of 2020 and slightly above experts’ projection.

Read management’s comments on SmileDirectClub’s Q1 earnings

The company’s shares have lost about 31% since the beginning of the year. They dropped during Monday’s extended trading after ending the regular session lower.

  • SmileDirectClub reports Q2 2020 earnings

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Viewing Highlight